The Beachbody Company, Inc.

NYSE:BODY

8.14 (USD) • At close March 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 72.36336.588102.193110.183119.01128.25134.948144.901148.166165.975358.272198.922216.266208.052223.108226.219224.283251.479218.484169.336
Cost of Revenue 20.814-19.00933.38233.80745.03853.21952.20453.56163.54561.309183.734105.905118.70873.06768.7768.11770.54670.92559.38948.847
Gross Profit 51.54955.59768.81176.37673.97275.03182.74491.3484.621104.666174.53893.01797.558134.985154.338158.102153.737180.554159.095120.489
Gross Profit Ratio 0.7121.520.6730.6930.6220.5850.6130.630.5710.6310.4870.4680.4510.6490.6920.6990.6850.7180.7280.712
Reseach & Development Expenses 12.59621.05919.38217.16217.78218.87918.6519.09620.84725.68648.26633.69736.19729.6826.94927.08925.47823.85222.37321.333
General & Administrative Expenses 11.6578.97411.7612.38813.5714.75911.88717.71619.23719.53239.16820.07321.15923.34617.23117.94618.58916.52314.52215.184
Selling & Marketing Expenses 30.97-5.42645.59256.30859.95269.12776.49276.57673.77493.145173.248106.444109.458153.782140.194144.696111.128123.98134.66694.226
SG&A 42.6273.54857.35268.69673.52283.88688.37994.29293.011112.677212.416126.517130.617177.128157.425162.642129.717140.503149.188109.41
Other Expenses 00.569000.1960.5710.4110.5690.2620.5710.378-0.0640.0490.2021.6541.2990.1110.1130.0340.408
Operating Expenses 55.22324.60776.73485.85891.304102.765107.029113.388113.858138.363260.682160.214166.814206.808184.374189.731155.195164.355171.561130.743
Operating Income -3.67430.99-7.923-9.482-16.169-29.004-24.178-22.048-29.237-33.697-86.144-67.197-163.83-71.823-30.036-31.629-1.45817.876-12.466-10.254
Operating Income Ratio -0.0510.847-0.078-0.086-0.136-0.226-0.179-0.152-0.197-0.203-0.24-0.338-0.758-0.345-0.135-0.14-0.0070.071-0.057-0.061
Total Other Income Expenses Net -2.02921.071-3.965-1.316-48.932-4.869-1.582-7.092-11.113-0.7111.848-7.04215.06830.4146.7390.5430.0161.701-0.2140.313
Income Before Tax -5.70352.061-11.888-10.798-65.101-32.603-25.76-29.14-46.45-34.408-84.296-74.239-148.762-41.409-23.297-30.453-1.44217.9-12.68-9.941
Income Before Tax Ratio -0.0791.423-0.116-0.098-0.547-0.254-0.191-0.201-0.313-0.207-0.235-0.373-0.688-0.199-0.104-0.135-0.0060.071-0.058-0.059
Income Tax Expense -0.045-0.154-0.115-0.067-0.0620.063-0.0120.048-1.517-0.549-0.562-0.706-2.8-1.487-10.857-0.39515.434.129-2.677-1.613
Net Income -5.74851.811-12.003-10.865-65.039-32.666-25.748-29.188-44.933-33.859-83.734-73.533-145.962-39.922-12.44-30.058-16.87213.771-10.003-8.328
Net Income Ratio -0.0791.416-0.117-0.099-0.547-0.255-0.191-0.201-0.303-0.204-0.234-0.37-0.675-0.192-0.056-0.133-0.0750.055-0.046-0.049
EPS -0.840.1-1.75-1.59-10.42-0.11-0.082-0.094-0.15-0.11-0.28-0.24-0.48-0.13-0.05-0.099-0.0550.045-0.033-0.027
EPS Diluted -0.840.1-1.75-1.59-10.42-0.11-0.082-0.094-0.15-0.11-0.28-0.24-0.48-0.13-0.05-0.099-0.0550.045-0.033-0.027
EBITDA -3.674-8.822-7.923-9.48214.797-17.4-12.955-10.766-7.576-10.959-45.836-45.674-169.275-53.189-14.716-16.60411.02929.309-1.8981.371
EBITDA Ratio -0.051-0.241-0.078-0.0860.124-0.136-0.096-0.074-0.051-0.066-0.128-0.23-0.783-0.256-0.066-0.0730.0490.117-0.0090.008